Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

AIVITA Biomedical doses first patients in Phase II AV-GBM-1 trial

Coronal MRI with contrast of a glioblastoma in a 15-year-old male. Credit: Christaras A.



  • AIVITA Biomedical

Go Top